LS

Lingampally Swamy

Director Director DIN 08571179
DIN 08571179 First appointment Sep 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2019
Shareholding value Locked Premium profile

About Lingampally Swamy

Data last updated:

Lingampally Swamy has 7 years in corporate governance. Formerly with 1 company, such as Plutus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08571179
Primary Designation Director
First Appointment 24 Sep 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Plutus Pharma Private Limited U24299TG2019PTC135673
Director24 Sep 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Plutus Pharma Private Limited
Premium access

Shareholding and investment profile for Lingampally Swamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lingampally Swamy

Lingampally Swamy has 7 years in corporate governance. Formerly with 1 company, such as Plutus Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Lingampally Swamy is associated with 0 companies as a director.

Lingampally Swamy has expertise in General Business.

Lingampally Swamy has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available